PharmaMar signs a license agreement for AplidinĀ® with Megapharm in Israel
PharmaMar (MSE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug AplidinĀ® (plitidepsin) in Israel and the...




